Logo image of ICOS.MI

INTERCOS SPA (ICOS.MI) Stock Fundamental Analysis

BIT:ICOS - Euronext Milan - IT0005455875 - Common Stock - Currency: EUR

12.04  -0.04 (-0.33%)

Fundamental Rating

3

Taking everything into account, ICOS scores 3 out of 10 in our fundamental rating. ICOS was compared to 13 industry peers in the Personal Care Products industry. While ICOS seems to be doing ok healthwise, there are quite some concerns on its profitability. ICOS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ICOS had positive earnings in the past year.
In the past year ICOS had a positive cash flow from operations.
Each year in the past 5 years ICOS has been profitable.
ICOS had a positive operating cash flow in each of the past 5 years.
ICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

The Return On Assets of ICOS (4.62%) is worse than 61.54% of its industry peers.
With a Return On Equity value of 10.18%, ICOS is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
ICOS has a Return On Invested Capital of 8.42%. This is in the lower half of the industry: ICOS underperforms 61.54% of its industry peers.
ICOS had an Average Return On Invested Capital over the past 3 years of 9.32%. This is below the industry average of 11.95%.
Industry RankSector Rank
ROA 4.62%
ROE 10.18%
ROIC 8.42%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ICOS.MI Yearly ROA, ROE, ROICICOS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

ICOS's Profit Margin of 4.56% is in line compared to the rest of the industry. ICOS outperforms 46.15% of its industry peers.
In the last couple of years the Profit Margin of ICOS has declined.
ICOS's Operating Margin of 8.80% is on the low side compared to the rest of the industry. ICOS is outperformed by 69.23% of its industry peers.
In the last couple of years the Operating Margin of ICOS has declined.
The Gross Margin of ICOS (19.19%) is worse than 92.31% of its industry peers.
ICOS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.8%
PM (TTM) 4.56%
GM 19.19%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
ICOS.MI Yearly Profit, Operating, Gross MarginsICOS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ICOS is still creating some value.
Compared to 1 year ago, ICOS has about the same amount of shares outstanding.
The number of shares outstanding for ICOS has been increased compared to 5 years ago.
The debt/assets ratio for ICOS is higher compared to a year ago.
ICOS.MI Yearly Shares OutstandingICOS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ICOS.MI Yearly Total Debt VS Total AssetsICOS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.29 indicates that ICOS is not in any danger for bankruptcy at the moment.
ICOS has a Altman-Z score (3.29) which is comparable to the rest of the industry.
The Debt to FCF ratio of ICOS is 8.40, which is on the high side as it means it would take ICOS, 8.40 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 8.40, ICOS is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.56 indicates that ICOS is somewhat dependend on debt financing.
ICOS's Debt to Equity ratio of 0.56 is in line compared to the rest of the industry. ICOS outperforms 53.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 8.4
Altman-Z 3.29
ROIC/WACC1.25
WACC6.76%
ICOS.MI Yearly LT Debt VS Equity VS FCFICOS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

ICOS has a Current Ratio of 1.81. This is a normal value and indicates that ICOS is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.81, ICOS belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
ICOS has a Quick Ratio of 1.19. This is a normal value and indicates that ICOS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.19, ICOS is doing good in the industry, outperforming 76.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.19
ICOS.MI Yearly Current Assets VS Current LiabilitesICOS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

ICOS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.28%.
The Earnings Per Share has been growing slightly by 1.57% on average over the past years.
The Revenue has been growing slightly by 7.76% in the past year.
The Revenue has been growing by 8.36% on average over the past years. This is quite good.
EPS 1Y (TTM)-7.28%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%12.38%
Revenue 1Y (TTM)7.76%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%13.03%

3.2 Future

The Earnings Per Share is expected to grow by 12.49% on average over the next years. This is quite good.
The Revenue is expected to grow by 1.81% on average over the next years.
EPS Next Y14.63%
EPS Next 2Y14.57%
EPS Next 3Y12.49%
EPS Next 5YN/A
Revenue Next Year6.49%
Revenue Next 2Y6.46%
Revenue Next 3Y6.38%
Revenue Next 5Y1.81%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICOS.MI Yearly Revenue VS EstimatesICOS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ICOS.MI Yearly EPS VS EstimatesICOS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.08, the valuation of ICOS can be described as rather expensive.
ICOS's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of ICOS to the average of the S&P500 Index (27.46), we can say ICOS is valued inline with the index average.
A Price/Forward Earnings ratio of 16.59 indicates a correct valuation of ICOS.
61.54% of the companies in the same industry are more expensive than ICOS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, ICOS is valued rather cheaply.
Industry RankSector Rank
PE 24.08
Fwd PE 16.59
ICOS.MI Price Earnings VS Forward Price EarningsICOS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ICOS is valued a bit cheaper than 69.23% of the companies in the same industry.
ICOS's Price/Free Cash Flow ratio is rather expensive when compared to the industry. ICOS is more expensive than 92.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 33.87
EV/EBITDA 8.61
ICOS.MI Per share dataICOS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ICOS's earnings are expected to grow with 12.49% in the coming years.
PEG (NY)1.65
PEG (5Y)15.33
EPS Next 2Y14.57%
EPS Next 3Y12.49%

More info and screens

2

5. Dividend

5.1 Amount

ICOS has a Yearly Dividend Yield of 1.63%.
ICOS's Dividend Yield is slightly below the industry average, which is at 2.60.
Compared to the average S&P500 Dividend Yield of 2.34, ICOS is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.63%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

37.10% of the earnings are spent on dividend by ICOS. This is a low number and sustainable payout ratio.
DP37.1%
EPS Next 2Y14.57%
EPS Next 3Y12.49%
ICOS.MI Yearly Income VS Free CF VS DividendICOS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICOS.MI Dividend Payout.ICOS.MI Dividend Payout, showing the Payout Ratio.ICOS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

INTERCOS SPA

BIT:ICOS (7/21/2025, 7:00:00 PM)

12.04

-0.04 (-0.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-04 2025-08-04
Inst Owners38.09%
Inst Owner ChangeN/A
Ins Owners32.17%
Ins Owner ChangeN/A
Market Cap1.16B
Analysts86.67
Price Target17.53 (45.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.63%
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP37.1%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.06%
PT rev (3m)-3.37%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.2%
Valuation
Industry RankSector Rank
PE 24.08
Fwd PE 16.59
P/S 1.09
P/FCF 33.87
P/OCF 11.67
P/B 2.43
P/tB 4.15
EV/EBITDA 8.61
EPS(TTM)0.5
EY4.15%
EPS(NY)0.73
Fwd EY6.03%
FCF(TTM)0.36
FCFY2.95%
OCF(TTM)1.03
OCFY8.57%
SpS11.05
BVpS4.95
TBVpS2.9
PEG (NY)1.65
PEG (5Y)15.33
Profitability
Industry RankSector Rank
ROA 4.62%
ROE 10.18%
ROCE 12.68%
ROIC 8.42%
ROICexc 11.19%
ROICexgc 16.95%
OM 8.8%
PM (TTM) 4.56%
GM 19.19%
FCFM 3.22%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ROICexc(3y)12.89%
ROICexc(5y)11.65%
ROICexgc(3y)22.3%
ROICexgc(5y)20.57%
ROCE(3y)14.06%
ROCE(5y)12.06%
ROICexcg growth 3Y0.58%
ROICexcg growth 5Y-13.66%
ROICexc growth 3Y4.35%
ROICexc growth 5Y-9.88%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 8.4
Debt/EBITDA 1.87
Cap/Depr 131.98%
Cap/Sales 6.12%
Interest Coverage 26.98
Cash Conversion 69.48%
Profit Quality 70.6%
Current Ratio 1.81
Quick Ratio 1.19
Altman-Z 3.29
F-Score5
WACC6.76%
ROIC/WACC1.25
Cap/Depr(3y)119.92%
Cap/Depr(5y)113.2%
Cap/Sales(3y)5.7%
Cap/Sales(5y)5.95%
Profit Quality(3y)77.95%
Profit Quality(5y)89.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.28%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%12.38%
EPS Next Y14.63%
EPS Next 2Y14.57%
EPS Next 3Y12.49%
EPS Next 5YN/A
Revenue 1Y (TTM)7.76%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%13.03%
Revenue Next Year6.49%
Revenue Next 2Y6.46%
Revenue Next 3Y6.38%
Revenue Next 5Y1.81%
EBIT growth 1Y1.78%
EBIT growth 3Y15.34%
EBIT growth 5Y2.71%
EBIT Next Year74.29%
EBIT Next 3Y27.67%
EBIT Next 5YN/A
FCF growth 1Y-28.87%
FCF growth 3Y14.23%
FCF growth 5Y-3.11%
OCF growth 1Y-3.62%
OCF growth 3Y17%
OCF growth 5Y3.39%